Itracure Cream is a topical formulation combining Ofloxacin (0.75% w/w), Ornidazole (2% w/w), Itraconazole (1% w/w), and Clobetasol (0.05% w/w), designed for the treatment of mixed bacterial, protozoal, fungal infections, and inflammatory dermatoses. Ofloxacin, a fluoroquinolone antibiotic, provides broad-spectrum antibacterial activity against gram-positive and gram-negative organisms. Ornidazole, a nitroimidazole derivative, exhibits potent antiprotozoal and anaerobic antibacterial effects, targeting protozoal infections and anaerobic bacteria. Itraconazole, a triazole antifungal agent, is effective against a wide range of dermatophytes, yeasts, and molds, addressing fungal infections of the skin. Clobetasol propionate, a potent corticosteroid, offers anti-inflammatory, antipruritic, and vasoconstrictive properties, helping to reduce inflammation, redness, and itching associated with dermatological conditions. The synergistic combination in Itracure Cream allows for comprehensive management of complex skin infections where multiple pathogens and inflammatory components coexist. This cream is indicated for use in conditions such as mixed bacterial and fungal infections with associated inflammation, including infected eczema, dermatitis, and other polymicrobial dermatoses. It should be used under medical supervision, with caution advised to avoid prolonged use due to the potential adverse effects of corticosteroids. Patients should follow prescribed directions to ensure optimal therapeutic outcomes and minimize risks.